Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort Study.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 23 2 2019
medline: 19 11 2019
entrez: 22 2 2019
Statut: ppublish

Résumé

Antiretroviral therapy is successfully administered to people living with HIV while they are incarcerated in most US prison systems, but interruptions in treatment are common after people are released. We undertook an observational cohort study designed to examine the clinical and psychosocial factors that influence linkage to HIV care and viral suppression after release from a single state prison system. In this report we describe baseline characteristics and 6-month post-incarceration HIV care outcomes for 170 individuals in Wisconsin. Overall, 114 (67%) individuals were linked to outpatient HIV care within 180 days of release from prison, and of these, 90 (79%) were observed to have HIV viral suppression when evaluated in the community. The strongest predictor of linkage to care in this study was participation in a patient navigation program: Those who received patient navigation were linked to care 84% of the time, compared to 60% of the individuals who received only standard release planning (adjusted OR 3.69, 95% CI 1.24, 10.96; P < 0.01). Findings from this study demonstrate that building and maintaining intensive patient navigation programs that support individuals releasing from prison is beneficial for improving transitions in HIV care.

Identifiants

pubmed: 30790170
doi: 10.1007/s10461-019-02437-4
pii: 10.1007/s10461-019-02437-4
pmc: PMC6703963
mid: NIHMS1522314
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2549-2557

Subventions

Organisme : NIDA NIH HHS
ID : K23 DA032306
Pays : United States
Organisme : NIDA NIH HHS
ID : R25 DA037190
Pays : United States
Organisme : NIDA NIH HHS
ID : R25DA037190
Pays : United States
Organisme : NIDA NIH HHS
ID : K23DA032306
Pays : United States

Références

AIDS. 1999 May 28;13(8):F59-62
pubmed: 10371167
Am J Public Health. 2004 Jul;94(7):1207-17
pubmed: 15226145
AIDS. 2007 May 11;21(8):965-71
pubmed: 17457090
HIV Clin Trials. 2007 Jul-Aug;8(4):205-12
pubmed: 17720660
Crim Behav Ment Health. 2008;18(2):88-103
pubmed: 18383201
JAMA. 2009 Feb 25;301(8):848-57
pubmed: 19244192
AIDS Care. 2009 Jun;21(6):708-14
pubmed: 19806487
Am J Public Health. 2011 Mar;101(3):546-53
pubmed: 21233439
J Urban Health. 2011 Jun;88(3):507-16
pubmed: 21302140
J Infect Dis. 2011 May 1;203(9):1215-21
pubmed: 21459814
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):181-7
pubmed: 21857529
Clin Infect Dis. 2011 Oct;53(7):725-31
pubmed: 21890777
Curr HIV/AIDS Rep. 2012 Dec;9(4):364-74
pubmed: 22968432
AIDS Patient Care STDS. 2013 Jan;27(1):5-16
pubmed: 23305257
AIDS Behav. 2013 Oct;17 Suppl 2:S83-5
pubmed: 23975472
JAMA Intern Med. 2014 May;174(5):721-9
pubmed: 24687044
Lancet HIV. 2014 Nov 1;1(2):e77-e84
pubmed: 25473651
Am J Public Health. 2015 Jul;105(7):e5-16
pubmed: 25973818
Lancet. 2016 Sep 10;388(10049):1033-1035
pubmed: 27427447
Lancet. 2016 Sep 10;388(10049):1089-1102
pubmed: 27427453
Lancet. 2016 Sep 17;388(10050):1228-48
pubmed: 27427455
Int J Drug Policy. 2017 Apr;42:22-25
pubmed: 28126684
AIDS Behav. 2019 Jan;23(Suppl 1):5-13
pubmed: 28283775
Health Justice. 2017 Dec;5(1):7
pubmed: 28589252
PLoS One. 2018 Feb 12;13(2):e0192074
pubmed: 29432472
Soc Sci Med. 2018 Aug;211:78-86
pubmed: 29913303

Auteurs

Ryan P Westergaard (RP)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Karli R Hochstatter (KR)

Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. khochsta@medicine.wisc.edu.
, 1685 Highland Ave - 4th Floor, Madison, WI, 53705, USA. khochsta@medicine.wisc.edu.

Paige N Andrews (PN)

Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Danielle Kahn (D)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Casey L Schumann (CL)

Wisconsin Division of Public Health AIDS/HIV Program, Madison, WI, USA.

Alec E Winzenried (AE)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Ajay K Sethi (AK)

Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Ronald E Gangnon (RE)

Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

James M Sosman (JM)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH